Cortisol in relation to problematic eating behaviours, adiposity and symptom profiles in Major Depressive Disorder

Jessica G Mills; Theresa A Larkin; Chao Deng; Susan J Thomas

doi:10.1016/j.cpnec.2021.100067

Cortisol in relation to problematic eating behaviours, adiposity and symptom profiles in Major Depressive Disorder

Compr Psychoneuroendocrinol. 2021 Jun 17:7:100067. doi: 10.1016/j.cpnec.2021.100067. eCollection 2021 Aug.

Authors

Jessica G Mills^{1

2

3}, Theresa A Larkin^{2

3}, Chao Deng^{2

3}, Susan J Thomas^{2

3}

Affiliations

¹ School of Psychology, Faculty of Arts, Social Sciences and Humanities, University of Wollongong, Wollongong, Australia.
² Illawarra Health and Medical Research Institute, University of Wollongong, Australia.
³ School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia.

Abstract

Aims: Major Depressive Disorder (MDD) is associated with an increased risk of chronic disease related to weight gain, problematic eating behaviours and neuroendocrine changes. MDD is frequently associated with altered hypothalamic-pituitary-adrenal axis activity and cortisol secretion, where cortisol has been implicated in regulating energy balance, food intake and depressogenic weight changes. However, little research has examined the relationships between cortisol, adiposity and depressogenic problematic eating behaviours.

Method: Plasma cortisol concentrations were compared between 37 participants with MDD reporting appetite/weight loss, 43 participants with MDD reporting appetite/weight gain, and 60 healthy controls, by sex. Associations between cortisol, indices of adiposity and problematic eating behaviours were then assessed after accounting for demographic variables and depressive symptoms. Depressive symptoms were assessed using the Depression subscale of the Depression, Anxiety and Stress Scale, and eating behaviours with the Dutch Eating Behaviours Questionnaire and Yale Food Addiction Scale.

Results: Participants with MDD reporting appetite/weight loss had higher cortisol compared to controls, and marginally higher cortisol than those with MDD reporting appetite/weight gain. Cortisol negatively and significantly accounted for unique variance in body mass index and waist circumference after accounting for variance associated with age, sex and depressive symptoms, however it was not a significant predictor of problematic eating behaviours, such as emotional eating or food addiction. Cortisol concentrations did not differ between sexes.

Conclusion: The results indicate that cortisol is related to lower indices of adiposity and depressogenic symptoms of appetite/weight loss but is not related to problematic eating behaviours and appetite increases in MDD. These findings provide further evidence that the melancholic and atypical subtypes of MDD are associated with differential neuroendocrine and anthropometric indices, as well as behavioural and symptom profiles. Further research investigating the temporal nature of the identified relationships may assist in facilitating the development of improved interventions for individuals affected by weight changes in MDD.

Keywords: Cortisol; Food addiction; Major depressive disorder; Problematic eating behaviours; Weight changes.